Michael Leney-Greene

Michael Leney-Greene is an experienced investigator currently working at AI Proteins since June 2023. Prior to this role, Michael served as a Senior Scientist at PureTech Health from August 2021 to June 2023, where responsibilities included the development of a gene therapy vehicle derived from human cell membranes and the design, production, and validation of in vitro antibody targeting constructs. Michael's career also includes a position as a Postdoctoral Researcher at the Broad Institute of MIT and Harvard between August 2019 and August 2021. Michael holds a Doctor of Philosophy (PhD) in Immunology from the University of Pennsylvania, earned from 2012 to 2019.